Experiences and challenges with the new European Clinical Trials Regulation
<p><strong>Background:</strong> The new European Medicines Agency (EMA) Clinical Trials Information System (CTIS), based on the Clinical Trials Regulation (CTR EU 536/2014), came into full effect on 31 January 2022 and was intended to provide an easier, more streamlined approach to...
Main Authors: | Patrick-Brown, TDJH, Bourner, J, Kali, S, Trøseid, M, Yazdanpanah, Y, Olliaro, P, Olsen, IC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2024
|
Similar Items
-
Experiences and challenges with the new European Clinical Trials Regulation
by: Thale D. J. H. Patrick-Brown, et al.
Published: (2024-01-01) -
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks
by: Kali, S, et al.
Published: (2023) -
Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design
by: Merson, L, et al.
Published: (2021) -
Clinical trials challenges - impact of the new clinical trial regulation on the conduct of clinical trials
by: Mugoša Snežana, et al.
Published: (2022-01-01) -
Challenges in clinical diagnosis of Clade I Mpox: Highlighting the need for enhanced diagnostic approaches
by: Bourner, J, et al.
Published: (2024)